Booster vaccination and influenza vaccination programme

A booster vaccination/re-vaccination can now be offered to several groups of people in Greenland who are assessed to be at increased risk of becoming seriously ill from COVID-19. A re-vaccination with a third dose of the vaccine provides better and long-lasting protection against COVID-19.

At the same time, influenza vaccination will be offered to selected groups of people who are considered to be at risk of becoming seriously ill from influenza. Influenza is a viral infection that can infect everyone, and which most frequently occurs during the winter season. For some people, the illness can be very serious and become life-threatening, and the course of the illness can become more severe if you have COVID-19 and influenza at the same time.

Vaccination with the booster vaccine and influenza vaccine is free and voluntary.

The booster vaccine and influenza vaccine are offered at the same time. When you attend your appointment to receive a dose of booster vaccine against COVID-19, you will also receive a dose of the influenza vaccine at the same time.

See the vaccination plan here.

The booster vaccine is offered when the citizen has completed his or her primary vaccination at least 6 months and 2 weeks ago. In some cities you’ll be called in for vaccination at the local health center, while other cities will have open drop-in vaccination. Please find the vaccination plan here.

You’ll be offered the same type of vaccine as the one you received for your primary vaccination.

People who in Denmark have been offered the booster vaccination and who meet the above criteria, will be offered the booster vaccination in Greenland, even though they did not receive their primary vaccination here. The requirement that your primary vaccination ended at least six months and two weeks ago, must be met.

The EU Commission has given its approval for both the third dose of the Comirnaty® Pfizer/BioNTech and the Spikevax® Moderna vaccine to be given as a re-vaccination to people aged 18 and over.

The booster vaccination may only be given at the earliest six months and two weeks after the person has received their second primary vaccination dose. You’ll be offered the same vaccine as for your primary vaccination.

For the booster vaccination with Comirnaty® Pfizer/BioNTech, you’ll be given the same dose as for the primary vaccination (30 microgram).

For the booster vaccination with Spikevax Moderna, you’ll be given the same dose as for the primary vaccination (50 microgram).

In some special cases, and after a specific medical assessment, an “off label” booster vaccination may be given if the citizen was not vaccinated with the vaccine from Pfizer-BioNTech for their primary vaccination.

The same precautions and contraindications apply as with the primary vaccination against COVID-19. Learn more about the precautions and contraindications here.

All vaccines can cause side effects, including vaccines against COVID-19. In most cases, the side effects are mild and temporary, and are common and most often harmless. The health authorities consider EU-approved vaccines to be very safe and well documented.

In the case of the booster vaccination, the same side-effects as the side-effects from the primary vaccination against COVID-19 can be expected.

Read more about the side effects here.

The following groups will be offered influenza vaccination:

  • People who have turned 65 years before the 15th of January 2022
  • Early retirees
  • People at a higher risk under the age of 65:
    • Diabetes mellitus
    • Chronic heart disease
    • Chronic lung disease
    • Chronic liver disease
    • Chronic kidney disease
    • Congenital or acquired immune deficiency
    • Affected respiration e.g. due to reduced muscle strength
    • Heavily overweight (BMI >40)
    • Pregnant women in the second and third trimester
    • Household members of severely immunosuppressed
    • Frontline employees in the healthcare system or the care sector, who works with care or treatment of citizens at a higher risk of becoming seriously ill from influenza

The individual will be medically assessed to decide whether he or she meets the criteria for the vaccination programme.

In Greenland, we use the influenza vaccine Fluenz Tetra®, which is a live attenuated vaccine.

The vaccination against influenza for children is given as a nasal spray, which is sprayed in both nostrils.

The vaccine is contra-indicated for some patient groups and immunosuppressant children. Siblings of immunosuppressant children should not be vaccinated with a live attenuated vaccine due to the potential risk of infecting the immunosuppressant child.

Children aged 2 to 6 years are offered two vaccinations, with an interval of at least four weeks.

If the child was previously vaccinated against influenza, the child will only be given a single vaccination.

The vaccination against influenza for children is given as a nasal spray, which is sprayed in both nostrils.

Very common (> 10 %)

Stomach-bowel irritation
Fatigue, discomfort
Reactions and discomfort at the injection site
Reduced appetite
Muscle pain
Drowsiness, irritability

Common (1 – 10%)

Diarrhoea, vomiting
Fever, chills
Joint pain